Abuja's new road project sparks debate as doctors decry failing hospitals
Abuja's new road project sparks debate as doctors decry failing hospitals
Abuja's new road project sparks debate as doctors decry failing hospitals
Federal Capital Territory (FCT) Minister Nyesom Wike has launched a new road project in Abuja while facing criticism over healthcare conditions. On Thursday, he inaugurated the construction of Arterial Road N1, linking Wuye District to Ring Road II. Meanwhile, doctors at three major hospitals have raised concerns about outdated medical facilities.
During the road project's launch, Wike defended his administration's priorities. He stated that the infrastructure upgrades were for Abuja's economic growth, not personal gain. The minister also dismissed accusations of neglecting other sectors, claiming every area of the FCT was receiving attention.
Wike responded firmly to threats of protests from healthcare workers. He refused to be pressured, insisting he would act in the best interest of the territory's development. His comments came as doctors at the National Hospital, University of Abuja Teaching Hospital, and National Obstetric Fistula Centre demanded urgent renovations. They highlighted critical shortages in ICU equipment, theatre suites, CT scanners, and X-ray machines. The minister pointed to President Bola Tinubu's 2025 budget, which includes N25 billion for FCT healthcare projects. Acting Head of Service Nancy Nathan also praised Wike's efforts, noting the modernisation of Abuja's infrastructure under his leadership.
The new road project is now underway, with Wike standing by his development plans. Doctors continue to push for improvements in hospital facilities. The N25 billion healthcare allocation remains a key part of the FCT's budget for next year.
Abuja's new road project sparks debate as doctors decry failing hospitals
A shiny new road divides Abuja—while doctors warn lives are at risk in crumbling hospitals. Who gets priority in Nigeria's capital?
Heartseed loses Novo Nordisk backing for groundbreaking heart failure therapy
A promising cardiac treatment now stands alone. After Novo Nordisk's abrupt exit, Heartseed must navigate Phase 2 trials—and an uncertain future—without its pharma giant ally.
Groundbreaking trial tests twice-yearly injection for stubborn high blood pressure
Could a simple injection every six months transform hypertension care? Roche's $300M-backed trial seeks answers for patients who struggle with current treatments.
Health Alert: Cold and Flu Season Hits Hardest Since 2022
This year's cold and flu season is shaping up to be the worst in years. Experts reveal surprising links between colds and COVID-19—but vaccinations remain critical.